Pfeffer Cary
Insider CIK 1591092 · EBIO Director · JNCE Director · NTGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-11-12 | 2021-11-16 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-09-15 | 2021-09-17 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-06-18 | 2021-06-22 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-06-10 | 2021-06-14 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-03-11 | 2021-03-15 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-11-17 | 2020-11-19 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2020-11-11 | 2020-11-13 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-07-02 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-06-29 | 13,550 | — | $0 | 13,550 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 18,500 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 14,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer | 2020-05-06 | 2020-05-06 | 0 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 18,500 | — | $0 | 18,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 15,700 | — | $0 | 15,700 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion deriv | 2018-06-29 | 2018-07-03 | 0 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion deriv | 2018-06-29 | 2018-07-03 | 0 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion | 2018-06-29 | 2018-07-03 | 0 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion | 2018-06-29 | 2018-07-03 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 13,550 | — | $0 | 13,550 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 0 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 0 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2016-06-08 | 2016-06-10 | 8,072 | — | $0 | 8,072 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2015-06-16 | 2015-06-18 | 8,072 | — | $0 | 8,072 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2014-03-20 | 2014-03-24 | 16,143 | — | $0 | 16,143 | SEC↗ |